Pharmaceutical Outsourcing: A Korean Perspective

Posted 04 February 2015 By Dong-Hyuk Jeon and Siegfried Schmitt, PhD

placeholder+image Background on the South Korean pharmaceutical industry and how companies select and choose suppliers and contractors, including regulatory affairs or regulatory compliance consultants or providers.

Share this article:

Categories: Drugs, Regulatory strategy, Features, Korea

Tags:

Regulatory Exchange: Latest Updates From the Community